Mitragynine Pseudoindoxyl updates: every status change, dated
The most recent Mitragynine Pseudoindoxyl record correction on file is November 3, 2026: Georgia, record corrected. status now shown: illegal. 38 changes recorded in total.
Hotearliest DEA action in 0 days (DEA-1570 / FR 2026-20943); notice of intent by the DEA (Drug Enforcement Administration), applies to every seller; enforcement action by the federal court (U.S. Attorney's Office, Northern District of Mississippi, with DEA), binds named parties only
active DEA notice of intent to issue a new temporary order keeping MGM-15 and MGM-16 in Schedule I without a threshold Federal · Notice of intent · DEA-1644; FR Doc. 2026-20942 · DEA (Drug Enforcement Administration) · applies to every seller DEA will issue a fresh two-year temporary order for MGM-15 and MGM-16 (no threshold) so they are separated from the thresholded pseudoindoxyl rule; the August 26, 2026 order stays in force until the new order publishes or expires August 26, 2028.
active DEA temporary scheduling order places mitragynine pseudoindoxyl, MGM-15 and MGM-16 in Schedule I for two years Federal · Emergency rule · DEA-1644; 91 FR 54948; FR Doc. 2026-17429 · DEA (Drug Enforcement Administration) · applies to every seller Mitragynine pseudoindoxyl, MGM-15 (dihydro-7-hydroxymitragynine) and MGM-16 (9-fluoro-dihydro-7-hydroxymitragynine), with isomers, esters, ethers and salts, became Schedule I effective August 26, 2026 through August 26, 2028; DOJ announced enforcement discretion for incidental trace pseudoindoxyl in botanical kratom.
active Notice of intent to temporarily schedule mitragynine pseudoindoxyl, MGM-15 and MGM-16 Federal · Notice of intent · FR 2026-13581 / 91 FR 40909 · DEA (U.S. Drug Enforcement Administration) · advisory, not binding Order "will be published in the Federal Register on or after August 5, 2026" and takes effect on publication. This is the single highest-value watch item for pseudoindoxyl -- it would replace interpretive isomer capture in AL, AR, IN and WI with a NAMED federal basis. Speciociliatine is in NEITHER docket.
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.